Clinical Trials on Hyperparathyroidism Tertiary in New Zealand
Total 64 results
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National... and other collaboratorsTerminated
-
Columbia UniversityMerck Sharp & Dohme LLCWithdrawnHyperparathyroidismUnited States
-
Chinese University of Hong KongCompletedHyperparathyroidism | Arterial StiffnessHong Kong
-
Roswell Park Cancer InstituteCompletedPrimary Hyperparathyroidism | Parathyroid Gland AdenomaUnited States
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedPrimary Hyperparathyroidism | Vitamin D DeficiencyUnited States
-
Weill Medical College of Cornell UniversityCompletedObesity | Vitamin D Deficiency | Secondary HyperparathyroidismUnited States
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedPrimary Hyperparathyroidism | Bone Diseases, Metabolic | Osteoporosis, Postmenopausal | Bone Loss, PostmenopausalUnited States
-
AmgenTerminatedChronic Kidney Disease, Secondary HyperparathyroidismUnited States, Belgium, Italy, Hungary, Czechia, France, Germany, Greece, Spain, Poland, Russian Federation, Ukraine, New Zealand, Slovakia, Lithuania, Portugal
-
Montefiore Medical CenterTerminatedSecondary Hyperparathyroidism | HypercalcemiaUnited States
-
Kenneth R. Phelps, M.D.Genzyme, a Sanofi CompanyCompletedHyperparathyroidism | Chronic Kidney DiseaseUnited States
-
ShireCompletedA Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in HypoparathyroidismHypoparathyroidism | Chronic HypoparathyroidismUnited States
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)WithdrawnPrimary Hyperparathyroidism | Vitamin D Deficiency | Osteoporosis | Osteopenia | HypercalcemiaUnited States
-
SanofiActive, not recruitingSecondary Hyperparathyroidism-Chronic Kidney DiseaseUnited States, Chile
-
AmgenCompletedHyperparathyroidism, Primary | HypercalcemiaUnited States, Canada, Russian Federation, Hungary, Australia, Portugal, Poland
-
Far Eastern Memorial HospitalCompleted
-
AbbottCompletedEnd Stage Renal Disease | Secondary HyperparathyroidismUnited States
-
AmgenCompletedSecondary Hyperparathyroidism, Chronic Kidney DiseaseUnited States, Czechia, Germany, France, Hungary, Greece, Belgium, Italy, Poland, Russian Federation, Ukraine
-
AmgenCompletedSecondary HyperparathyroidismUnited States, Italy, Belgium, Switzerland, Hungary, Spain, Turkey, Poland, Portugal, United Kingdom, Czech Republic, Macedonia, The Former Yugoslav Republic of
-
Winthrop University HospitalTerminatedSecondary Hyperparathyroidism | Kidney Failure | Hyperphosphatemia | HypercalcemiaUnited States
-
Thomas Nickolas, MD MSCompletedVascular Calcification | Chronic Kidney Disease Mineral and Bone Disorder | Hyperparathyroidism; Secondary, Renal | Renal OsteodystrophyUnited States
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States, Italy, Belgium, Denmark, Switzerland, Canada, Turkey, Spain, Austria, Germany, Hungary, Greece, France, Poland, Russian Federation, Czechia, Latvia, Lithuania, New Zealand, Portugal, Sweden, Estonia
-
AmgenTerminatedHyperparathyroidism | Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary | Kidney DiseaseUnited States, Belgium, Hungary, Spain, Australia, Germany, Poland, Mexico, Russian Federation, Slovakia
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismKorea, Republic of, Taiwan, Hong Kong, China, India, Malaysia
-
AmgenTerminatedChronic Kidney Disease | Hyperparathyroidism, SecondaryUnited States, Belgium, Italy, Hungary, Czechia, France, Germany, Poland, Netherlands, Russian Federation, New Zealand, Mexico, Slovakia
-
John P. BilezikianNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Columbia UniversityFDA Office of Orphan Products DevelopmentRecruiting
-
National Institute of Diabetes and Digestive and...Unknown
-
Amolyt PharmaActive, not recruitingEndocrine System Diseases | Parathyroid Diseases | Chronic HypoparathyroidismUnited States, United Kingdom, Spain, Italy, Netherlands, Denmark, Hungary, Portugal, Germany, France, Canada, Poland
-
Genzyme, a Sanofi CompanyCompletedRenal Failure | Secondary Hyperparathyroidism | Chronic Renal InsufficiencyUnited States, Puerto Rico
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | End Stage Kidney Disease | Chronic Kidney Disease Mineral and Bone Disorder | Renal OsteodystrophyUnited States
-
AbbVie (prior sponsor, Abbott)North America Pediatric Renal Trials and Collaborative Studies (NAPRTCS)TerminatedEnd-Stage Renal Disease | Secondary HyperparathyroidismUnited States
-
Thomas Nickolas, MD MSNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Indiana...RecruitingChronic Kidney Diseases | Secondary Hyperparathyroidism | Renal Osteodystrophy | Bone Turnover Rate Disorder | CKD-MBDUnited States
-
AbbottCompletedHemodialysis | Chronic Kidney Disease | Secondary HyperparathyroidismUnited States, Czech Republic, Denmark, Germany, Greece, Italy, Netherlands, Portugal, Russian Federation, Spain, Sweden, United Kingdom
-
John P. BilezikianShire; NPS PharmaUnknownHypoparathyroidismUnited States
-
AmgenRecruitingChronic Kidney Disease | Secondary HyperparathyroidismKorea, Republic of, United States, India, Singapore, Taiwan, Argentina, Malaysia, Russian Federation, Turkey, Ukraine
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, Switzerland, Canada, Turkey, Spain, Australia, Austria, Israel, Czechia, Hungary, Poland, France, Russian Federation, Germany, Denmark, Greece, Latvia, Lithuania, Netherlands, New Zealand, Portugal, Sweden
-
Thomas Nickolas, MD MSTerminatedOsteoporosis | Kidney Transplant; Complications | Renal OsteodystrophyUnited States
-
Pathalys PharmaLaunch TherapeuticsRecruitingSecondary Hyperparathyroidism | End-stage Kidney Disease (ESKD)United States, Bulgaria, Spain, Portugal, Poland, Serbia
-
Ascendis Pharma A/SActive, not recruitingEndocrine System Diseases | Parathyroid Diseases | HypoparathyroidismUnited States, Canada, Denmark, Germany, Italy, Norway
-
ShireCompletedHypoparathyroidismUnited States
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingHypoparathyroidismUnited States, Spain, Denmark, Germany, Austria, Canada, Greece, Sweden, Italy, Norway, United Kingdom
-
Pathalys PharmaLaunch TherapeuticsRecruitingSecondary Hyperparathyroidism | End Stage Kidney DiseaseUnited States, Bulgaria, Portugal, Spain, Serbia, Poland
-
Deltanoid PharmaceuticalsCompletedKidney Failure, Chronic | Hyperparathyroidism, SecondaryUnited States
-
ShireCompletedHypoparathyroidismUnited States, Hungary, Canada, Denmark
-
OPKO Health, Inc.CompletedBreast Cancer | Bone Neoplasms | Prostate Cancer | Hypocalcemia | Hyperparathyroidism, SecondaryUnited States
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Canada, France, Australia, Israel, Czechia, Hungary, Netherlands, Spain, Poland, Russian Federation, Italy, Sweden, Germany
-
ShireCompletedHypoparathyroidismUnited States, Denmark, Canada, Hungary, United Kingdom, Belgium, France, Italy